CME Group Inc. (NASDAQ:CME) Shares Sold by Embree Financial Group

Embree Financial Group decreased its holdings in CME Group Inc. (NASDAQ:CME) by 4.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 50,929 shares of the financial services provider’s stock after selling 2,350 shares during the quarter. CME Group makes up 2.0% of Embree Financial Group’s portfolio, making the stock its 9th biggest position. Embree Financial Group’s holdings in CME Group were worth $11,237,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. Oak Harvest Investment Services grew its holdings in CME Group by 66.5% during the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after acquiring an additional 18,017 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after purchasing an additional 8,443 shares in the last quarter. Duality Advisers LP bought a new stake in CME Group in the first quarter valued at about $1,455,000. SG Americas Securities LLC raised its stake in CME Group by 312.2% during the first quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after buying an additional 42,996 shares in the last quarter. Finally, Cetera Investment Advisers raised its stake in CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ:CME opened at $228.32 on Friday. The firm’s 50 day moving average is $216.92 and its two-hundred day moving average is $208.34. The firm has a market capitalization of $82.21 billion, a P/E ratio of 25.97, a PEG ratio of 7.76 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.12.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue was up 12.7% compared to the same quarter last year. During the same period last year, the firm earned $2.30 EPS. Analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Piper Sandler boosted their price target on CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Oppenheimer increased their target price on shares of CME Group from $228.00 to $245.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Morgan Stanley lifted their price target on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday. Finally, Citigroup increased their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $220.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.